Search Results - sickle+cell+anemia

2 Results

Sort By:

Aptamer Based Sickle Cell Anemia Therapeutic

INVENTION NOVELTY: This technology is a set of RNA aptamers capable of reducing sickle hemoglobin (HbS) polymerization, which has therapeutic potential in reducing vaso-occlusion and ischemia in sickle cell disease patients. VALUE PROPOSITION: Sickle cell anemia is a genetically inherited disease affecting 1 in 400 African American and up to 2% of the...

Published: 6/27/2024 | Inventor(s): James Casella, Shirley Purvis, Emily Barron-Casella, Yolanda Fortenberry, Jeffrey Keefer

Keywords(s): Biologics, Disease Indication, Genetic Disorders, Nucleic Acid, Sickle Cell Anemia, Therapeutic Matter, Therapeutic Substance, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Genetic Diseases > Sickle Cell Anemia, Clinical and Disease Specializations > Hematology, Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Research Tools > Nucleic Acids, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Genetic Diseases, Technology Classifications > Research Tools, Technology Classifications > Therapeutic Modalities

C05053: Small Molecules Epigenetic Inhibitors for Cancer Prevention and Treatment.

C05053: Small Molecules Epigenetic Inhibitors for Cancer Prevention and Treatment.Value Proposition: • Compounds represent first in class small molecule agents for inhibition of MBD2 activity. • Reversible inhibition. • Truly epigenetic agents, unlike other epigenetic drugs which appear to have cytotoxic effects independent of epigenetic...

Published: 6/27/2024 | Inventor(s): Xiaohui Lin, Zachery Reichert, Traci Speed, Srinivasan Yegnasubramanian, William Nelson

Keywords(s): Antagonists/Inhibitors, Cancers, Disease Indication, Genetic Disorders, Non-novel, Off-the-shelf, Predicted Novelty, Sickle Cell Anemia, Single, Small Molecules, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Hematology > Sickle Cell Disease